In conclusion, we showed that pre-culturing CD8+ T-cells on substrate-immobilized CCL21 + ICAM1 increases both the proliferation of T-cells and their tumor-killing capacity, leading to enhanced tumor suppression abilities. The gene discussed is CCL21; the disease is neoplasm.